Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD.
The item "Ebitda-Per-Share" stands at 0.333 Hong Kong Dollars as of 06/30/2025, the highest value since 09/30/2023.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Ebitda Per Share" stands at 0.333 HKD. This represents an increase of 0.89 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 57.36 percent compared to the value the year prior.
The 1 year change in percent is 57.36.
The 3 year change in percent is 1.69.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Ebitda Per Share | 905,699,262,464.00 |
![]() | Johnson & Johnson - Ebitda Per Share | 486,508,953,600.00 |
![]() | AbbVie Inc - Ebitda Per Share | 399,570,305,024.00 |
![]() | Roche Holding AG - Ebitda Per Share | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Ebitda Per Share | 280,205,508,085.11 |